Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Alveolar Bone Atrophy

2-amino-5-phosphonovalerate has been researched along with Alveolar Bone Atrophy in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gray, C1
Marie, H1
Arora, M1
Tanaka, K1
Boyde, A1
Jones, S1
Attwell, D1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Alveolar Bone Atrophy

ArticleYear
Glutamate does not play a major role in controlling bone growth.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2001, Volume: 16, Issue:4

    Topics: 2-Amino-5-phosphonovalerate; Alveolar Bone Loss; Amino Acid Transport System X-AG; Animals; Animals,

2001